ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,992Medicare Part D Prescriptions Filled, Including Refills

Rank: 183 out of 2035

$756K Total Retail Price of All Prescriptions

Rank: 117 out of 2035

613 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 9,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$76 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 594 546 1 1
LEVOTHYROXINE SODIUM 368 355 2 4
OMEPRAZOLE 352 337 3 5
LISINOPRIL 295 271 4 3
LOSARTAN-HYDROCHLOROTHIAZIDE 240 225 5 47
METOPROLOL TARTRATE 218 212 6 8
AMLODIPINE BESYLATE 189 176 7 6
HYDROCODONE-ACETAMINOPHEN 186 150 S3 8 2
LOSARTAN POTASSIUM 181 170 9 15
METFORMIN HCL 178 168 10 9
METOPROLOL SUCCINATE 168 160 11 16
FUROSEMIDE 161 151 12 7
TAMSULOSIN HCL 155 148 13 25
WARFARIN SODIUM 154 142 14 11
NABUMETONE 144 138 15 190
PANTOPRAZOLE SODIUM 134 118 16 42
AZITHROMYCIN 134 116 16 39
ATORVASTATIN CALCIUM 133 125 18 13
PREDNISONE 132 121 19 36
PRAVASTATIN SODIUM 125 107 20 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 107 21 26
SERTRALINE HCL 99 93 22 23
ATENOLOL 98 88 23 10
CIPROFLOXACIN HCL 97 88 24 63
ZOLPIDEM TARTRATE 95 89 25 21
JANUVIA 93 85 26 85
CARVEDILOL 93 85 26 22
HYDROCHLOROTHIAZIDE 90 81 28 12
ADVAIR DISKUS 89 71 29 38
GLIMEPIRIDE 83 80 30 55
DOXAZOSIN MESYLATE 83 83 30 111
AMITRIPTYLINE HCL 82 82 R 32 101
GABAPENTIN 81 69 33 14
ZETIA 78 78 34 84
SYNTHROID 77 75 35 83
ALLOPURINOL 76 72 36 34
TRAMADOL HCL-ACETAMINOPHEN 70 68 37 196
CALCITONIN-SALMON 68 67 38 266
FLUTICASONE PROPIONATE 67 61 39 29
TRIAMTERENE-HCTZ 66 64 40 35
POTASSIUM CHLORIDE 65 65 41 18
CLOPIDOGREL 64 64 42 30
ACTOS 62 53 43 124
DONEPEZIL HCL 60 60 44 24
FENTANYL 58 58 S2 45 53
GEMFIBROZIL 58 58 45 114
FINASTERIDE 54 52 47 105
DILTIAZEM 24HR ER 53 30 48 143
ISOSORBIDE MONONITRATE ER 52 44 49 32
SINGULAIR 52 34 49 119
GLYBURIDE 51 40 R 51 74
NEXIUM 51 35 51 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.